Company / Revenue
IOVANCE BIOTHERAPEUTICS, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$263.5M
FY2025
5-year range
$1.2M / $263.5M
FY2021-FY2025
Trend
+60.6%
vs FY2024
Sector context
#85 of 155
Health Care
What the data says
At $264M, IOVANCE BIOTHERAPEUTICS, INC.'s revenue ranks #85 of 155 in the Health Care sector. Revenue has increased for 3 consecutive years, from $0 in FY2018 to $264M in FY2025.
Based on SEC 10-K filings.
$264M in FY2025.
Improved from $1M to $264M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 155 in Health CareTop 55% of 155This company $263.5M Sector average $4.5B
▼
-94.1% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 60.6% year-over-year.
- Ranks #85 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $263.5M | +60.6% |
| FY2024 | $164.1M | +13699.0% |
| FY2023 | $1.2M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026